KALYDECO 13.4 mg, granules in a sachet 56 sachets
Active ingredients: Ivacaftor
Commercialized according to BDPMDispensing in France: Prescription only
Granules56 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KALYDECO 13,4 mg, granulés en sachet
- Pharmaceutical form
- granulés
- Route of administration
- orale
- Presentation description
- 56 (4 x 14) sachets BoPET : polyéthylène téréphtalate biaxialement orienté polyéthylène aluminium
- Marketing authorisation holder
- VERTEX PHARMACEUTICALS (EUROPE) LIMITED
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Jul 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67851912CIP73029420CIP133400930294208Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IVACAFTORgranulés | 13,4 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.